NCT01627041 2026-04-13Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 2 Active not recruiting178 enrolled
NCT06504459 2026-04-13Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AMLOHSU Knight Cancer InstitutePhase 2 Recruiting40 enrolled